KCE reports 118A Titel : Voordelen, nadelen en haalbaarheid van het invoeren van ‘<strong>Pay</strong> <strong>for</strong> <strong>Quality</strong>’ programma’s in België Auteurs : Lieven Annemans (UGent), Pauline Boeckxstaens (UGent), Liesbeth Borgermans (KULeuven), Delphine De Smedt (UGent), Christiane Duchesnes (Université de Liège), Jan Heyrman (KULeuven), Roy Remmen (Universiteit Antwerpen), Walter Sermeus (KULeuven), Carine Van Den Broeke (KULeuven), Pieter Van Herck (KULeuven), Marc Vanmeerbeek (Université de Liège), Sara Willems (UGent), Kristel De Gauquier (KCE) Reviewers : Christian Léonard (KCE), Imgard Vinck (KCE) Externe experten : Hugo Casteleyn (AZ Sint-Blasius Dendermonde), Pierre Chevalier (UCL), Xavier de Béthune (Alliance Nationale des Mutualités Chrétiennes), Pierre Gillet (Université de Liège), Margareta Haelterman (Federale Acknowledgements : Overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu), Annelies Van Linden (Domus Medica) België: Bert Aertgeerts (CEBAM, KULeuven), Dirk Broeckx (APB), Geneviève Bruwier (ULg, SSMG, Forum des Associations de Médecins Généralistes), Piet Calcoen (DKV), Xavier de Béthune (Alliance Nationale des Mutualités Chrétiennes), Jo De Cock (RIZIV), Christiaan Decoster (Federale Overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu), Peter Degadt (Zorgnet Vlaanderen), Didier de Laminne de Bex (DKV), Jan De Maeseneer (UGent), Ri De Ridder (RIZIV), Daniel Désir (CHU Brugmann), Jos Desmedt (Domus Medica), Jacques De Toeuf (CHIREC, ABSYM), Alain De Wever (ULB), Pierre Drielsma (Maisons Médicales), Guy Durant (UCL), Micky Fierens (LUSS), Pierre Gillet (ULg), Johan Hellings (Ziekenhuis Oost-Limburg), Marc Justaert (Landsbond der Christelijke Mutualiteiten), Johan Kips (UZLeuven), Jean-Marc Laasman (Union nationale des mutualités socialistes), Roger Lonfils (Communauté française Wallonie-Bruxelles, Direction générale de la Santé), Catherine Lucet (Union nationale des mutualités socialistes), Pascal Meeus (RIZIV), Marc Moens (BVAS), Dominique Pestiaux (UCL), Michel Roland (ULB, CEBAM), Robert Rutsaert (ASGB), Marco Schetgen (ULB), Erik Schokkaert (KULeuven), Carine Serano (Ligue des Usagers des Services de Santé), Piet Vandenbussche (UGent), Walter Van Den Eede (Agentschap Inspectie Welzijn, Volkgezondheid en Gezin), Chris Vander Auwera (Vlaams Agentschap Zorg en Gezondheid), Philippe Vandermeeren (Groupement Belge des Omnipraticiens), Michel Van Hoegaarden (Federale Overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu), Bernard Vercruysse (UCL, Forum des Associations de Médecins Généralistes), Michel Vermeylen (Association des Médecins de Famille, ABSYM), Arthur Vleugels (KULeuven), Ilse Weeghmans (Vlaams Patiëntenplat<strong>for</strong>m) Internationaal: Mark Ashworth (King’s College, London, UK), Jozé Braspenning (Scientific Institute <strong>for</strong> <strong>Quality</strong> of Health Care, the Netherlands), Alyna Chien (University of Chicago, US), Tim Coleman (University of Leeds, UK), Sheryl Damberg (RAND, US), Stephen Duckett (Queensland Health Government, Australia & Alberta Health Services, Canada), Adams Dudley (University of Cali<strong>for</strong>nia, US), Robert Fleetcroft (University of East Anglia, UK), Christine Gardel (Haute Autorité de Santé, France), Ruth McDonald (University of Manchester, UK), Gary McLean (University of Glasgow, Scotland, UK), Peggy McNamara (AHRQ, US), Christopher Millett (Imperial College, London, UK), Karen Murphy (Temple University, Philadelphia, US), Martin Roland (University of Manchester/ Cambridge, UK), Meredith Rosenthal (Harvard University, US), Ian Scott (Princess Alexandra Hospital, Queensland, Australia), Colin
Externe validatoren : Simpson (University of Aberdeen, Scotland, UK), Abd Tahrani (University of Birmingham, UK) Marc Jegers (VUB), Matthew Sutton (University of Manchester, UK), Cordula Wagner (Nivel & Vrije Universiteit Amsterdam medisch centrum, Nederland) Conflict of interest : Hugo Casteleyn geeft regelmatig voordrachten tijdens seminaries of opleidingen voor zorginstellingen. Xavier de Béthune werkt voor een organisatie die mogelijks een financieel voor- of nadeel zal ondervinden wanneer P4Q programmas geïmplementeerd zouden worden. Disclaimer : De externe experten hebben aan het wetenschappelijke rapport meegewerkt dat daarna aan de validatoren werd voorgelegd. De validatie van het rapport volgt uit een consensus of een meerderheidsstem tussen de validatoren. Alleen het KCE is verantwoordelijk voor de eventuele resterende vergissingen of onvolledigheden alsook voor de aanbevelingen aan de overheid. Layout: Ine Verhulst Brussel, 16 november 2009 Studie nr 2008-12 Domein: Health Services Research (HSR) MeSH: Salaries and Fringe Benefits ; Reimbursement, Incentive ; Fees and Charges ; <strong>Quality</strong> Assurance, Health Care ; <strong>Quality</strong> Control ; Health Services Accessibility NLM classificatie: W 84.4 Taal : Nederlands, Engels Formaat : Adobe® PDF (A4) Wettelijk depot: D/2009/10.273/50 Elke gedeeltelijke reproductie van dit document is toegestaan mits bronvermelding. Dit document is beschikbaar van op de website van het Federaal Kenniscentrum voor de gezondheidszorg. Hoe refereren naar dit document? Annemans L, Boeckxstaens P, Borgermans L, De Smedt D, Duchesnes C, Heyrman J, Remmen R, Sermeus W, Van Den Broecke C, Van Herck P, Vanmeerbeek M, Willems S, De Gauquier K. Voordelen, nadelen en haalbaarheid van de introductie van ‘<strong>Pay</strong> <strong>for</strong> <strong>Quality</strong>’ programma’s in België. Health Services Research (HSR). Brussel: Federaal Kenniscentrum voor de Gezondheidszorg (KCE). 2009. KCE Reports vol 118A. D/2009/10.273/50
- Page 1 and 2: Voordelen, nadelen en haalbaarheid
- Page 3: Voordelen, nadelen en haalbaarheid
- Page 7 and 8: KCE Reports 118A Pay for Quality ii
- Page 9 and 10: KCE Reports 118A Pay for Quality iv
- Page 11 and 12: KCE Reports 118A Pay for Quality vi
- Page 13 and 14: KCE Reports 118A Pay for Quality vi
- Page 15 and 16: KCE Reports 118 Pay for Quality 1 S
- Page 17 and 18: KCE Reports 118 Pay for Quality 3 9
- Page 19 and 20: KCE Reports 118 Pay for Quality 5 W
- Page 21 and 22: KCE Reports 118 Pay for Quality 7 S
- Page 23 and 24: KCE Reports 118 Pay for Quality 9 2
- Page 25 and 26: KCE Reports 118 Pay for Quality 11
- Page 27 and 28: KCE Reports 118 Pay for Quality 13
- Page 29 and 30: KCE Reports 118 Pay for Quality 15
- Page 31 and 32: KCE Reports 118 Pay for Quality 17
- Page 33 and 34: KCE Reports 118 Pay for Quality 19
- Page 35 and 36: KCE Reports 118 Pay for Quality 21
- Page 37 and 38: KCE Reports 118 Pay for Quality 23
- Page 39 and 40: KCE Reports 118 Pay for Quality 25
- Page 41 and 42: KCE Reports 118 Pay for Quality 27
- Page 43 and 44: KCE Reports 118 Pay for Quality 29
- Page 45 and 46: KCE Reports 118 Pay for Quality 31
- Page 47 and 48: KCE Reports 118 Pay for Quality 33
- Page 49 and 50: KCE Reports 118 Pay for Quality 35
- Page 51 and 52: KCE Reports 118 Pay for Quality 37
- Page 53 and 54: KCE Reports 118 Pay for Quality 39
- Page 55 and 56:
KCE Reports 118 Pay for Quality 41
- Page 57 and 58:
KCE Reports 118 Pay for Quality 43
- Page 59 and 60:
KCE Reports 118 Pay for Quality 45
- Page 61 and 62:
KCE Reports 118 Pay for Quality 47
- Page 63 and 64:
KCE Reports 118 Pay for Quality 49
- Page 65 and 66:
KCE Reports 118 Pay for Quality 51
- Page 67 and 68:
KCE Reports 118 Pay for Quality 53
- Page 69 and 70:
KCE Reports 118 Pay for Quality 55
- Page 71 and 72:
KCE Reports 118 Pay for Quality 57
- Page 73 and 74:
KCE Reports 118 Pay for Quality 59
- Page 75 and 76:
KCE Reports 118 Pay for Quality 61
- Page 77 and 78:
Clinical domain (disease) KCE Repor
- Page 79 and 80:
KCE Reports 118 Pay for Quality 65
- Page 81 and 82:
KCE Reports 118 Pay for Quality 67
- Page 83 and 84:
KCE Reports 118 Pay for Quality 69
- Page 85 and 86:
KCE Reports 118 Pay for Quality 71
- Page 87 and 88:
KCE Reports 118 Pay for Quality 73
- Page 89 and 90:
KCE Reports 118 Pay for Quality 75
- Page 91 and 92:
KCE Reports 118 Pay for Quality 77
- Page 93 and 94:
KCE Reports 118 Pay for Quality 79
- Page 95 and 96:
KCE Reports 118 Pay for Quality 81
- Page 97 and 98:
KCE Reports 118 Pay for Quality 83
- Page 99 and 100:
KCE Reports 118 Pay for Quality 85
- Page 101 and 102:
KCE Reports 118 Pay for Quality 87
- Page 103 and 104:
KCE Reports 118 Pay for Quality 89
- Page 105 and 106:
KCE Reports 118 Pay for Quality 91
- Page 107 and 108:
KCE Reports 118 Pay for Quality 93
- Page 109 and 110:
KCE Reports 118 Pay for Quality 95
- Page 111 and 112:
KCE Reports 118 Pay for Quality 97
- Page 113 and 114:
KCE Reports 118 Pay for Quality 99
- Page 115 and 116:
KCE Reports 118 Pay for Quality 101
- Page 117 and 118:
KCE Reports 118 Pay for Quality 103
- Page 119 and 120:
KCE Reports 118 Pay for Quality 105
- Page 121 and 122:
KCE Reports 118 Pay for Quality 107
- Page 123 and 124:
KCE Reports 118 Pay for Quality 109
- Page 125 and 126:
KCE Reports 118 Pay for Quality 111
- Page 127 and 128:
KCE Reports 118 Pay for Quality 113
- Page 129 and 130:
KCE Reports 118 Pay for Quality 115
- Page 131 and 132:
KCE Reports 118 Pay for Quality 117
- Page 133 and 134:
KCE Reports 118 Pay for Quality 119
- Page 135 and 136:
KCE Reports 118 Pay for Quality 121
- Page 137 and 138:
KCE Reports 118 Pay for Quality 123
- Page 139 and 140:
KCE Reports 118 Pay for Quality 125
- Page 141 and 142:
KCE Reports 118 Pay for Quality 127
- Page 143 and 144:
KCE Reports 118 Pay for Quality 129
- Page 145 and 146:
KCE Reports 118 Pay for Quality 131
- Page 147 and 148:
KCE Reports 118 Pay for Quality 133
- Page 149 and 150:
KCE Reports 118 Pay for Quality 135
- Page 151 and 152:
KCE Reports 118 Pay for Quality 137
- Page 153 and 154:
KCE Reports 118 Pay for Quality 139
- Page 155 and 156:
KCE Reports 118 Pay for Quality 141
- Page 157 and 158:
KCE Reports 118 Pay for Quality 143
- Page 159 and 160:
KCE Reports 118 Pay for Quality 145
- Page 161 and 162:
KCE Reports 118 Pay for Quality 147
- Page 163 and 164:
KCE Reports 118 Pay for Quality 149
- Page 165 and 166:
KCE Reports 118 Pay for Quality 151
- Page 167 and 168:
KCE Reports 118 Pay for Quality 153
- Page 169 and 170:
KCE Reports 118 Pay for Quality 155
- Page 171 and 172:
KCE Reports 118 Pay for Quality 157
- Page 173 and 174:
KCE Reports 118 Pay for Quality 159
- Page 175 and 176:
KCE Reports 118 Pay for Quality 161
- Page 177 and 178:
KCE Reports 118 Pay for Quality 163
- Page 179 and 180:
KCE Reports 118 Pay for Quality 165
- Page 181 and 182:
KCE Reports 118 Pay for Quality 167
- Page 183 and 184:
KCE Reports 118 Pay for Quality 169
- Page 185 and 186:
KCE Reports 118 Pay for Quality 171
- Page 187 and 188:
KCE Reports 118 Pay for Quality 173
- Page 189 and 190:
KCE Reports 118 Pay for Quality 175
- Page 191:
KCE Reports 118 Pay for Quality 177
- Page 194 and 195:
Wettelijk depot : D/2008/10.273/50
- Page 196 and 197:
37. HTA Magnetische Resonantie Beel
- Page 198:
108. Tiotropium in de behandeling v